The text starts here.

News Release

FOR IMMEDIATE RELEASE
June 8, 2017

LAUNCH OF PAIN TREATMENT LYRICA® OD TABLET FORMULATION IN JAPAN

Pfizer Japan Inc.
Eisai Co., Ltd.

Pfizer Japan Inc. (Headquarters: Tokyo, President and Representative Director: Ichiro Umeda, “Pfizer”) and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) have announced that Lyrica® OD Tablets 25mg, 75mg, 150mg (OD tablet: orally disintegrating tablet), a new formulation following pain treatment Lyrica Capsules (pregabalin), will be launched on June 8.

Lyrica Capsules are co-promoted in Japan by Pfizer and Eisai, with both companies working to provide information on its proper use. Likewise, Lyrica OD Tablets will also be co-promoted by both companies in Japan.

Lyrica is indicated for use in patients with neuropathic pain and pain associated with fibromyalgia. Many of these patients are elderly, and there are cases of patients having difficulty swallowing. Lyrica OD Tablets dissolve swiftly inside the mouth, making it an easy form for these patients to take, and are expected to lead to increased convenience when taking medicine.

Through Lyrica, Pfizer and Eisai will continue to contribute to improvement of quality of life in patients suffering from neuropathic pain and pain associated with fibromyalgia.

 Lyrica OD Tablets 25mg, 75mg, 150mg

Media Inquiries:

Pfizer Japan Inc.    Corporate Communications
Telephone: +81-3-5309-6644

Eisai Co., Ltd.    Public Relations Department
Telephone: +81-3-3817-5120

Pain Treatment Lyrica OD Tablets Outline

Product Name: Lyrica® OD Tablet 25mg・75mg・150mg
Generic Name: Pregabalin
Approval Date: February 17, 2017
NHI Price Listing Date May 31, 2017
Launch Date June 8, 2017
Manufactured and Marketed by: Pfizer Japan Inc.
Co-promoted by: Eisai Co., Ltd.
Indications and Usage Neuropathic pain,
Pain associated with fibromyalgia
Dosage and Administration

Neuropathic pain
The usual adult dosage for oral use begins at 150 mg/day of pregabalin twice daily, and should be gradually increased to 300 mg/day over 1 week or more. Dosage should be adjusted, depending on age and symptoms. However, the maximum daily dose should not be beyond 600 mg and should be orally administered twice daily.

Pain associated with fibromyalgia
The usual adult dosage for oral use begins at 150 mg/day of pregabalin twice daily, and should be gradually increased to 300 mg/day over 1 week or more and then maintained at 300-450 mg/day as need. Dosage should be adjusted, depending on age and symptoms. However, the maximum daily dose should not be beyond 450 mg and should be orally administered twice daily.

Price Lyrica OD Tablet 25mg:      67.80 yen
Lyrica OD Tablet 75mg:     112.90 yen
Lyrica OD Tablet 150mg:   155.00 yen
Packaging Lyrica OD Tablet 25mg:     100 tablets (PTP), 500 tablets (PTP)
Lyrica OD Tablet 75mg:     100 tablets (PTP), 500 tablets (PTP)
Lyrica OD Tablet 150mg:   100 tablets (PTP)